John Wells Logan

John Wells Logan

Auto-generated profile, based on publicly available information

John Wells Logan

The Ohio State University and Nationwide Children’s Hospital, Columbus, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2021 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
SVShilpa Vyas-Read
Shilpa Vyas-Read
JLJ. Wells Logan
J. Wells Logan
ACAlain Cuna
Alain Cuna
JMJoana Machry
Joana Machry
KLKristin T. Leeman
Kristin T. Leeman
JLJoanne M. Lagatta
Joanne M. Lagatta

1 August 2019 in Paediatric Respiratory Reviews
Verified
Journal Article
Closed access
JLJ. Wells Logan
J. Wells Logan
SLSusan K. Lynch
Susan K. Lynch
JCJennifer Curtiss
Jennifer Curtiss
ESEdward G. Shepherd
Edward G. Shepherd

12 January 2017 in Journal of Perinatology
Verified
Journal Article
Open access
PDF file
JLJ W Logan
J W Logan
ODO Dammann
O Dammann
EAE N Allred
E N Allred
CDC Dammann
C Dammann
KBK Beam
K Beam
FIfor the ELGAN Study Investigators
for the ELGAN Study Investigators
Objective: A neonatal illness severity score, The Score for Neonatal Acute Physiology-II (SNAP-II), predicts neurodevelopmental impairments at two years of age among children born extremely preterm. We sought to evaluate to what extent SNAP-II is predictive of cognitive and other neurodevelopmental impairments at 10 years of age. Study Design: In a cohort of 874 children born before 28 weeks of gestation, we prospectively collected clinical, physiologic and laboratory data to calculate SNAP-II for each infant. When the children were 10 years old, examiners who were unaware of the child’s medical history assessed neurodevelopmental outcomes, including neurocognitive, gross motor, social and communication functions, diagnosis and treatment of seizures or attention deficit hyperactivity disorder (ADHD), academic achievement, and quality of life. We used logistic regression to adjust for potential confounders. Results: An undesirably high SNAP-II (⩾30), present in 23% of participants, was associated with an increased risk of cognitive impairment (IQ, executive function, language ability), adverse neurological outcomes (epilepsy, impaired gross motor function), behavioral abnormalities (attention deficit disorder and hyperactivity), social dysfunction (autistic spectrum disorder) and education-related adversities (school achievement and need for educational supports. In analyses that adjusted for potential confounders, Z-scores ⩽−1 on 11 of 18 cognitive outcomes were associated with SNAP-II in the highest category, and 6 of 18 were associated with SNAP-II in the intermediate category. Odds ratios and 95% confidence intervals ranged from 1.4 (1.01, 2.1) to 2.1 (1.4, 3.1). Similarly, 2 of the 8 social dysfunctions were associated with SNAP-II in the highest category, and 3 of 8 were associated with SNAP-II in the intermediate category. Odds ratios and 95% confidence intervals were slightly higher for these assessments, ranging from 1.6 (1.1, 2.4) to 2.3 (1.2, 4.6). Conclusion: Among very preterm newborns, physiologic derangements present in the first 12 postnatal hours are associated with dysfunctions in several neurodevelopmental domains at 10 years of age. We are unable to make inferences about causality.

6 May 2021 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
MPM.N. Parikh
M.N. Parikh
MCM. Chen
M. Chen
ABA. Braimah
A. Braimah
JKJ. Kline
J. Kline
KMK. McNally
K. McNally
NPNehal A. A. Parikh
Nehal A. A. Parikh
Cardiomyocyte (CM) proliferation and maturation are highly linked processes, however, the extent to which these processes are controlled by a single signaling axis is unclear. Here, we find the Hedgehog (HH)-GLI2-CKS1B cascade regulates the transition between proliferation and maturation in hiPSC-CMs. Initially, we found a significant enrichment of GLI2-signaling in CMs from patients with ischemic heart failure (HF) or dilated-cardiomyopathy (DCM), indicating initiation of fetal programs in the stressed heart. Developmentally, we showed downregulation of GLI-signaling in adult human CM, adult murine CM, and in late-stage hiPSC-CM. In early-stage, proliferative hiPSC-CM, inhibition of Hh- or GLI-proteins enhanced CM maturation. Mechanistically, we identified CKS1B, a new effector of GLI2 and showed that GLI2 binds the CKS1B promoter to regulate its expression. CKS1B overexpression in late-stage hiPSC-CMs led to increased proliferation with loss of maturation. Thus, the Hh-GLI2-CKS1B axis regulates the proliferation-maturation transition and provides targets to enhance cardiac tissue engineering and regenerative therapies.

23 March 2021 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
MKMatthew J. Kielt
Matthew J. Kielt
JLJ. Wells Logan
J. Wells Logan
CBCarl H. Backes
Carl H. Backes
KRKristina M. Reber
Kristina M. Reber
LNLeif D. Nelin
Leif D. Nelin
ESEdward G. Shepherd
Edward G. Shepherd

1 September 2014 in Cytokine
Verified
Journal Article
Closed access
JLJ. Wells Logan
J. Wells Logan
EAElizabeth N. Allred
Elizabeth N. Allred
RFRaina N. Fichorova
Raina N. Fichorova
SEStephen Engelke
Stephen Engelke
ODOlaf Dammann
Olaf Dammann
ALAlan Leviton
Alan Leviton